Full-Time

AI Enablement Manager

ClearView Healthcare Partners

ClearView Healthcare Partners

501-1,000 employees

Life sciences strategy consulting for biopharma

No salary listed

San Francisco, CA, USA + 2 more

More locations: New York, NY, USA | Newton, MA, USA

In Person

The posting also describes the role location as Boston, New York, or San Francisco.

Bachelor's

Category
AI & Machine Learning (1)
Required Skills
LLM
Claude
Agile
Data Analysis

Get referred to ClearView Healthcare Partners

See people who can refer or advise you

Requirements
  • A bachelor's degree in computer science, information technology, engineering, life sciences, or another related field, or equivalent experience.
  • At least 5 years of experience in technology, product, or consulting roles, including at least 2 years working hands-on with large language models, prompt engineering, or artificial-intelligence-driven workflows.
  • Demonstrated experience running projects end-to-end using Agile or other approaches and shipping artificial intelligence or software tools into production use.
Responsibilities
  • Maintain a firmwide view of in-flight and proposed artificial intelligence initiatives across Claude, Perplexity, Kenley, and custom coding tools.
  • Partner with the Chief Information Officer, Data & Analytics leadership, and pillar leads to prioritize, sequence, and resource high-impact use cases.
  • Author, test, and iterate on prompts, agents, and artificial intelligence workflows that improve how consulting teams scope, research, analyze, and deliver work.
  • Identify new use cases by working with billable teams and turning recurring pain points into reusable artificial intelligence assets.
  • Inherit artificial intelligence tools, prompts, and prototypes built and maintained by billable consultants, then productionize, document, and support them.
  • Lead requirements gathering and define scope, objectives, deliverables, and success metrics for artificial intelligence enablement initiatives.
  • Keep the Chief Information Officer, Data & Analytics, pillar leads, consulting leadership, and information technology informed of initiative progress, decisions, and trade-offs.
  • Translate technical details for non-technical audiences and non-technical requirements for technical audiences.
  • Serve as the primary liaison with information technology, compliance, legal, and learning and development to ensure tools are secure, comply with client confidentiality requirements, and are rolled out responsibly.
  • Partner with learning and development to design and deliver training, office hours, prompt libraries, and support materials.
  • Gather feedback from consulting teams and firm leadership, surface friction points, and iterate on prompts and workflows based on real usage.
  • Measure usage, time saved, and quality impact of artificial intelligence tools and workflows.
  • Share impact results with leadership and recommend where to expand investment, discontinue initiatives, or invest next.
Desired Qualifications
  • Strong working knowledge of large language models, prompt engineering, retrieval and agent patterns, and modern artificial intelligence coding tools such as Claude, Perplexity, Cursor, and Copilot, with the ability to translate business needs into practical artificial intelligence solutions.
  • Demonstrated ability to lead and influence cross-functional teams and coach colleagues without direct line authority.
  • Strong communication and enablement skills, including the ability to tailor messages for technical and non-technical audiences ranging from senior leadership to junior consultants.
  • Strong analytical and product-thinking skills, including identifying high-leverage artificial intelligence use cases, making data-informed prioritization decisions, and assessing initiative impact.
  • Comfort with ambiguity and rapid change, including continuously evaluating new tools and adjusting the firm's approach.
  • Strong organization and prioritization skills, including managing a portfolio of concurrent artificial intelligence initiatives and keeping them on track.
ClearView Healthcare Partners

ClearView Healthcare Partners

View

ClearView Healthcare Partners provides strategic consulting services exclusively for the life sciences sector, guiding pharmaceutical, biotechnology, medical devices, and diagnostics firms through decisions from discovery to commercialization. It completes project work with 100% of a dedicated team focused on a single client engagement, pairing rigorous scientific knowledge with business strategy, with many consultants holding life sciences PhDs. The firm differentiates itself through its strict one-client-per-project model, sector-only focus, and deep scientific expertise, plus international expansion to serve global clients. Its goal is to help life sciences companies grow, advance product development, and secure market access, creating value across the entire product lifecycle.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Newton, Massachusetts

Founded

2008

Get referred to ClearView Healthcare Partners

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ClearView invested $4 million in Epistemic AI on January 10, 2025.
  • The March 2026 Salesforce-driven expert-network overhaul improves screening, scheduling, and compensation.
  • Seven open roles and 2026 hiring across Boston, London, San Francisco, and Gurgaon signal demand.

What critics are saying

  • Epistemic AI integration exposes ClearView to expensive technology bets if adoption stalls.
  • Expert-network Salesforce changes in March 2026 can disrupt delivery and consultant utilization.
  • AI tools commoditize strategy decks, squeezing premium advisory pricing by 2027.

What makes ClearView Healthcare Partners unique

  • 100% dedicated project teams keep ClearView focused on one client engagement at a time.
  • PhD-heavy consultants and founders from McKinsey, Leerink, and banking anchor scientific credibility.
  • London and Zurich offices, opened by 2026, deepen cross-border biopharma coverage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Remote Work Options

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Wellness Program

Mental Health Support

Professional Development Budget

Conference Attendance Budget

Stock Options

Company Equity

Family Planning Benefits

Fertility Treatment Support

Home Office Stipend

Phone/Internet Stipend

Parental Leave

Adoption Assistance

Meal Benefits

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

11%

1 year growth

11%

2 year growth

12%
PR Newswire
Mar 12th, 2025
The Addf'S Diagnostics Accelerator Authors New Paper On Ocular Biomarker Landscape, Highlighting Ocular Tests As A Tool For Early Detection Of Alzheimer'S Disease

New findings published in Alzheimer's Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's, while ocular tests offer a non-invasive alternative for detecting at-risk patient populations NEW YORK, March 12, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) authored a first-of-its-kind paper, "Unlocking ocular biomarkers for early detection of Alzheimer's disease," providing a landscape review of ocular biomarkers as another tool, alongside blood biomarkers, to aid in the early detection of Alzheimer's disease. The paper, which was published in Alzheimer's Dementia, shares an informed perspective on the role of ocular biomarkers in the broader Alzheimer's diagnostics space and what defines a true ocular biomarker, while also highlighting the potential for ocular screening to identify at-risk patients who would otherwise go undiagnosed. The authors' assessment is based on hours of in-depth interviews with leading neurologists, ophthalmologists, optometrists, and primary care physicians from across the United States

Citybiz
Jan 13th, 2025
ClearView Invests $4M in Epistemic AI

ClearView Healthcare Partners announced a $4 million minority investment in Epistemic AI to enhance its EpistemicGPT platform, which combines AI with a vast biomedical knowledge graph. This partnership aims to improve ClearView's service offerings by integrating AI technology, enhancing research and drug development processes. The collaboration underscores a commitment to advancing biomedical research and healthcare outcomes through innovative technology solutions.

Citybiz
Jan 13th, 2025
ClearView Healthcare Partners Invest In Epistemic AI

BOSTON, MA and WESTPORT, CT – 13 January 2025: ClearView Healthcare Partners, the leading life sciences strategic consultancy supporting Pharma... Read More

Digital Therapeutics Alliance
Nov 15th, 2023
DTx Commercialization Launch Playbook Case Study

Digital Therapeutics Alliance is thrilled to announce the release of its latest white paper in collaboration with Clearview Healthcare Partners!

Foundation Fighting Blindness
Feb 13th, 2023
The Foundation's long-term impact on moving the inherited retinal disease field forward towards treatments and cures. — Foundation Fighting Blindness

The Foundation Fighting Blindness partnered with ClearView Healthcare Partners to evaluate the impact of its funding and resources since 2005 on the clinical understanding and development of novel therapies for inherited retinal diseases (IRDs).